Want to see HK:1419 full AI Analyst Report?
Human Health Holdings Ltd. (1419) AI Stock Analysis
Human Health Holdings Ltd.
(HKEX:1419)
Stable balance sheet and recovering cash flows form the main support, aided by reasonable valuation; revenue volatility and soft technical momentum limit upside.
Human Health Holdings Ltd. (1419) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 288.46M
- Dividend Yield
- 3.95%
- Average Volume (3M)
- 49.51K
- Price to Earnings (P/E)
- 10.6
- Beta (1Y)
- 0.40
- Revenue Growth
- 4.23%
- EPS Growth
- 3.03%
- Country
- Hong Kong
- Employees
- 455
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Human Health Holdings Ltd. Business Overview & Revenue Model
Company Description
Operating as an investment holding company, Human Health Holdings Limited delivers a comprehensive range of healthcare services across Hong Kong. Its primary care offerings encompass a wide array of services such as routine consultations, diagnostic...
Human Health Holdings Ltd. Financial Statement Overview
Summary
Inconsistent revenue and sharply lower profitability pressure the income statement, offset by a conservative balance sheet with low leverage and markedly improved cash flows.
Income Statement
45NeutralBalance Sheet
78PositiveCash Flow
68Positive| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 671.67M | 671.67M | 644.43M | 590.82M | 1.00B | 1.12B |
| Gross Profit | 311.34M | 311.34M | 296.57M | 269.85M | 593.24M | 659.68M |
| EBITDA | 106.17M | 106.17M | 99.11M | 104.06M | 323.25M | 513.25M |
| Net Income | 27.13M | 27.13M | 26.34M | 24.19M | 180.84M | 375.31M |
Balance Sheet | ||||||
| Total Assets | 1.07B | 1.07B | 1.07B | 1.06B | 1.26B | 1.16B |
| Cash, Cash Equivalents and Short-Term Investments | 523.53M | 523.53M | 439.90M | 489.58M | 641.26M | 270.33M |
| Total Debt | 133.32M | 133.32M | 134.54M | 146.46M | 182.49M | 188.47M |
| Total Liabilities | 271.95M | 271.95M | 290.22M | 289.71M | 455.27M | 416.67M |
| Stockholders Equity | 794.60M | 794.60M | 781.75M | 766.67M | 808.22M | 741.95M |
Cash Flow | ||||||
| Free Cash Flow | 134.81M | 134.81M | 89.54M | -28.17M | 580.24M | 219.30M |
| Operating Cash Flow | 142.84M | 142.84M | 97.30M | 11.34M | 664.26M | 295.81M |
| Investing Cash Flow | -95.41M | -95.41M | 3.71M | -47.63M | -335.34M | -203.22M |
| Financing Cash Flow | -55.09M | -55.09M | -93.63M | -122.66M | -178.28M | -67.45M |
Human Health Holdings Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1419, the sentiment is Negative. The current price of 0.76 is below the 20-day moving average (MA) of 0.77, below the 50-day MA of 0.76, and below the 200-day MA of 0.78, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 47.52 is Neutral, neither overbought nor oversold. The STOCH value of 18.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1419.
Human Health Holdings Ltd. Peers Comparison
Overall Rating
- HK:141963Neutral
HK:386954Neutral
HK:663948Neutral
HK:238945Neutral
HK:072242Neutral
HK:388641Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:1419 | 63Neutral | HKD 288.46M | 10.63 | 3.43% | 3.95% | 4.23% | 3.03% |
| HK:3869 | 54Neutral | HKD 467.79M | -143.62 | -0.41% | ― | 3.16% | -101.02% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:6639 | 48Neutral | HKD 1.03B | 31.06 | 1.27% | ― | ― | ― |
| HK:2389 | 45Neutral | HKD 448.35M | -4.35 | -6.22% | ― | -27.63% | -16.33% |
| HK:0722 | 42Neutral | HKD 292.35M | -3.79 | -10.76% | 9.04% | -1.37% | -334.69% |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1419 | Human Health Holdings Ltd. | 0.76 | -0.08 | -9.52% | |
| HK:2389 | Beijing Health (Holdings) Limited | 0.07 | -0.00 | -2.63% | |
| HK:3869 | Hospital Corporation of China Ltd | 3.38 | -2.61 | -43.49% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.11 | -40.07% | |
| HK:6639 | Arrail Group Ltd. | 1.83 | -0.09 | -4.74% | |
| HK:0722 | UMP Healthcare Holdings Limited | 0.36 | -0.07 | -16.67% |
Human Health Holdings Ltd. Corporate Events
Human Health Holdings Sets AGM to Approve Accounts, Dividend and Share Issuance Mandate
Human Health Holdings has called its annual general meeting for 8 December 2026 in Hong Kong to approve the audited financial statements for the year ended 30 June 2026 and to consider declaring a final dividend. Shareholders will also vote on appoin...
Human Health Holdings Delivers Steady FY2026 Growth and Raises Final Dividend
Human Health Holdings Limited reported a 4.2% rise in revenue to HK$671.7 million for the year ended 30 June 2026, with profit attributable to shareholders increasing 3.0% to HK$27.1 million. Basic earnings per share edged up to HK7.1 cents, and the...
Human Health Holdings Declares Final Dividend for FY2026
Human Health Holdings Limited has declared a final ordinary cash dividend of HKD 0.031 per share for the financial year ended 30 June 2026. The ex-dividend date is set for 11 December 2026, with the record date on 16 December 2026 and payment schedul...
Human Health Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend
Human Health Holdings Limited, a Hong Kong-listed healthcare services group, operates medical clinics and related health businesses serving local communities and corporate clients. The company leverages a board combining executive and independent dir...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 01, 2026